Skip to main content
SpringerLink
Log in

Blood transfusion in newborn

  • Symposium on hematology — II(Neonatal Hematology)
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Premature infants are among the most frequently transfused groups of patients, usually receiving red cells. The immaturity of the immune system, its lesser ability to cope with a metabolic load and the presence of maternal antibodies, all complicate the picture. Conservation of blood to minimize losses and the need for replacement transfusion is an important strategy that has already been successful in reducing the need for transfusion on neonatal units. The advent of erythropoietin provides another strategy for reducing the need for transfusion. It is unfortunate that the sickest patients who require the most transfusion poorly respond to erythropoietin. Main concern is the long-term consequences of transfusion. Presently the aim is to minimize transfusion risks and give transfusions only when they are indicated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Simson J, Kinsey S. Paediatric transfusion.Vox Sang 2001; 81: 1–5.

    Article  Google Scholar 

  2. Maier RF, Sonntag JS, Walka MM, Liu G, Metze BC, Obladen M. Changing practices of red blood cell transfusions in infants with birth weights less than 1000 g.J Pediatr 2000; 136:220–224.

    Article  PubMed  CAS  Google Scholar 

  3. Widness JA, Seward VJ, Kromer IJ, Burmeister LF, Bell EF, Strauss RG. Changing patterns of red blood cell transfusion in very low birth weight infants.J Pediatr 1996; 129: 680–687.

    Article  PubMed  CAS  Google Scholar 

  4. Wang-Rodriguez J, Mannino FL, Liu E, Lane TA. A novel strategy to limit blood donor exposure and blood waste in multiply transfused premature infants.Transfusion 1996; 36: 64–70.

    Article  PubMed  CAS  Google Scholar 

  5. Strauss RG: Red blood cell transfusion practices in the neonate.Perinatal Hematology 1995; 22 (3): 641–655.

    CAS  Google Scholar 

  6. Strauss RG: Managing the anemia of prematurity: Red blood cell transfusions versus recombinant erythropoietin.Transfusion Medicine Reviews 2001; 15(3): 213–223.

    Article  PubMed  CAS  Google Scholar 

  7. Brown MS, Jones MA, Ohls RKet al Single-dose pharmacokinetics of recombinant human erythropoietin in preterm infants after intravenous and subcutaneous administration.J Pediatr 1993; 122: 655.

    Article  PubMed  CAS  Google Scholar 

  8. Mercer JS. Current best evidence: A review of the literature on umbilical cord clamping.J Midwifery Womens Health 2001; 46: 402–414.

    Article  PubMed  CAS  Google Scholar 

  9. Jeter EK, Spivey MA. Red blood cell transfusions for selected neonatal and pediatric patients. In Reid ME, Nance SJ, eds.Red Cell Transfusion: A Practical Guide. Totowa: Humana Press Inc, 1998:89–104.

    Google Scholar 

  10. Downey P. Recombinant human erythropoietin as a treatment for anemia of prematurity.J Perinat Neonatal Nurs 1997; 11: 57–68.

    PubMed  CAS  Google Scholar 

  11. Asch J, Wedgwood JF. Optimizing the approach to anemia in the preterm infants: Is there a role for erythropoietin therapy?J Perinatol 1997; 17:276–282.

    PubMed  CAS  Google Scholar 

  12. Canadian Paediatric Society Nutrition Committee. Meeting the iron needs of infants and young children: An update.CMAJ 1991; 144:1451–1454.

    Google Scholar 

  13. American Academy of Pediatrics Committee on Nutrition. Nutritional needs of low birth weight infants.Pediatrics 1985; 75:976–980.

    Google Scholar 

  14. Griffiths G, Lall R, Chatfield Set al. Randomised controlled double blind study of role of recombinant erythropoietin in the prevention of chronic lung disease.Arch Dis Child 1997; 76: F190–2.

    Article  CAS  Google Scholar 

  15. Kumar P, Shankaran S, Krishnan RG. Recombinant human erythropoietin therapy for treatment of anemia of prematurity in very low birth weight infants: A randomized, double blind, placebo-controlled trial.J Perinatol 1998; 18:173–177.

    PubMed  CAS  Google Scholar 

  16. Testa M, Reali A, Copula Met al. Role of rHuEpo on blood transfusions in preterm infants after the fifteenth day of life.Pediatr Hemat Oncol 1998; 15:415–420.

    Article  CAS  Google Scholar 

  17. Trentesaux AS, Egreteau L, Santerne B, Morville P. Recombinant human erythropoietin in premature infants. Evaluation of a one-year experience.Arch Pediatr 1999; 6: 944–951.

    Article  PubMed  CAS  Google Scholar 

  18. Ohls RK, Ehrenkranz RA, Wright LLet al. Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birthweight: A multicenter, randomized, controlled trial.Pediatrics 2001; 108: 934–942.

    Article  PubMed  CAS  Google Scholar 

  19. Ohls RK, Ehrenkranz RA, Wright LLet al. Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: A multicenter, randomized, controlled trial.Pediatrics 2001; 108: 934–942.

    Article  PubMed  CAS  Google Scholar 

  20. Vamvakas EC, Strauss RG. Meta-analysis of controlled clinical trials studying the efficacy of rHuEPO in reducing blood transfusions in the anemia of prematurity.Transfusion 2001; 41:406–415.

    Article  PubMed  CAS  Google Scholar 

  21. Roseff SD, Naomi LCL, Manno CS. Guidelines for assessing appropriateness of pediatric transfusion.Transfusion 2002; 42: 1398–1413.

    Article  PubMed  Google Scholar 

  22. Gorlin JB, ed.Standards for Blood Banks and Transfusion Services 21st edn. Bethesda MD: American Association of Blood Banks. 2002.

    Google Scholar 

  23. Strauss RG, Burmeister LF, Johnson K, Cress G, Cordle D. Feasibility and safety of AS-3 red blood cells for neonatal transfusions. J Pediatr 2000; 136:215–219.

    Article  PubMed  CAS  Google Scholar 

  24. Voak D, Cann R, Finney RDet al. Guidelines for administration of blood products: Transfusion of infants and neonates. British Committee for Standards in Hematology Blood Transfusion Task Force.Transfusion Medicine 1994; 4:63–69.

    PubMed  CAS  Google Scholar 

  25. Preiksaitis JK. Indications for use of cytomegalovirus seronegative blood products.Trans Med Rev 1991; 5:1–17.

    CAS  Google Scholar 

  26. Rosen NR, Weidner JG, Bolot HD, Rosen DS. Prevention of transfusion associated graft-versus-host disease: Selection of an adequate dose of gamma irradiation.Transfusion 1993; 33: 125–127.

    Article  PubMed  CAS  Google Scholar 

  27. Akahoshi M, Takanashi M, Masuda Met al. A case of transfusion-associated graft-versus-host disease not prevented by white cell-reduction filtere.Transfusion 1992; 32:169–172.

    Article  PubMed  CAS  Google Scholar 

  28. Manno CS, Friedman DF. Neonatal transfusion. In Spitzer A, ed.Intensive Care of the Fetus and Neonate. St. Louis: MosbyYearbook, 1996; 1112–1139.

    Google Scholar 

  29. Choudhry VP. Platelet therapy.Indian J Pediatr 2002; 69(9): 779.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, All India Institute of Medical Sciences, New Delhi, India

    M. Mahapatra (Assistant Professor) & V. P. Choudhry

Authors
  1. M. Mahapatra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. P. Choudhry
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Mahapatra.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mahapatra, M., Choudhry, V.P. Blood transfusion in newborn. Indian J Pediatr 70, 909–914 (2003). https://doi.org/10.1007/BF02730598

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02730598

Key words

Search

Navigation